|
gptkbp:instanceOf
|
gptkb:government_agency
|
|
gptkbp:abbreviation
|
gptkb:EMA
|
|
gptkbp:budget
|
over €300 million (2023)
|
|
gptkbp:collaboratesWith
|
gptkb:European_Parliament
gptkb:World_Health_Organization
national competent authorities
|
|
gptkbp:coordinates
|
gptkb:EU_medicines_regulatory_network
|
|
gptkbp:director
|
gptkb:Emer_Cooke
|
|
gptkbp:employs
|
over 900 staff
|
|
gptkbp:established
|
1995
|
|
gptkbp:fullName
|
gptkb:European_Medicines_Agency
|
|
gptkbp:hasCommittee
|
gptkb:Committee_for_Advanced_Therapies
gptkb:Committee_for_Medicinal_Products_for_Human_Use
gptkb:Committee_for_Medicinal_Products_for_Veterinary_Use
gptkb:Committee_for_Orphan_Medicinal_Products
gptkb:Committee_on_Herbal_Medicinal_Products
gptkb:Pediatric_Committee
gptkb:Pharmacovigilance_Risk_Assessment_Committee
|
|
gptkbp:headquartersLocation
|
gptkb:London,_United_Kingdom
gptkb:Amsterdam,_Netherlands
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
EMA
|
|
gptkbp:jurisdiction
|
gptkb:European_Union
|
|
gptkbp:language
|
English
|
|
gptkbp:mainBuilding
|
gptkb:Domenico_Scarlattilaan_6,_Amsterdam
|
|
gptkbp:memberOf
|
gptkb:Heads_of_Medicines_Agencies
|
|
gptkbp:monitors
|
adverse drug reactions
|
|
gptkbp:movedToAmsterdam
|
2019
|
|
gptkbp:oversees
|
biosimilars
pharmaceutical companies
veterinary medicines
generics
herbal medicines
advanced therapy medicinal products
vaccine approval in the EU
COVID-19 vaccine authorisation
centralised authorisation procedure
orphan drug designation
|
|
gptkbp:parentOrganization
|
gptkb:European_Union
|
|
gptkbp:provides
|
scientific advice
public health information
guidance for clinical trials
information on medicine safety
|
|
gptkbp:regulates
|
medicines for human use
medicines for veterinary use
|
|
gptkbp:responsibleFor
|
pharmacovigilance
evaluation of medicinal products
supervision of medicinal products
|
|
gptkbp:website
|
https://www.ema.europa.eu/
|
|
gptkbp:bfsParent
|
gptkb:cancer
|
|
gptkbp:bfsLayer
|
4
|